Form 4 for CMMB Chemomab Therapeutics Ltd.
Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-14 · accession 0001178913-22-001120 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-15 | 2022-03-14 | CMMB | Pfost Dale R | CEO, Dir | P - Purchase | $3.98 | +2,500 | 1,800 | New | +$9,943 |
| D | 2022-03-15 | 2021-10-25 | CMMB | Pfost Dale R | CEO, Dir | A - Grant | $0.00 | +459.4K | 459.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2022-03-14 | P | A | 700 | $3.97 | 2,500 | D | — | — | (F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. |
| 2 | Common | American Depositary Shares | 2022-03-14 | P | A | 1,800 | $3.98 | 1,800 | D | — | — | (F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. |
| 3 | Derivative | Option to Purchase American Depositary Shares | 2021-10-25 | A | A | 459,353 | $0.00 | 459,353 | D | $10.05 · — to 2031-10-25 | 459,353 American Depositary Shares | (F2) No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. (F3) The options vest and become exercisable over a period of four (4) years with one quarter (1/4) of the options vesting on October 25, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service. |